AA
TLSI icon

Ancora Advisors’s TriSalus Life Sciences TLSI Stock Holding History

Ancora Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,098
Closed -$21K – 1948
2022
Q3 		$21K Hold
2,098
– – ﹤0.01% 1326
2022
Q2 		$21K Hold
2,098
– – ﹤0.01% 1426
2022
Q1 		$21K Sell
2,098
-4,202
-67% -$41.5K ﹤0.01% 1540
2021
Q4 		$62K Buy
6,300
+1,200
+24% +$11.9K ﹤0.01% 1164
2021
Q3 		$51K Buy
+5,100
New +$49.9K ﹤0.01% 1183

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DFCM
Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ancora Advisors's TLSI Position: Q4 2022 in Review

Ancora Advisors sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 2,098 shares — an estimated $21K sold.

Ancora Advisors first reported a position in TLSI in Q3 2021 and held it in 5 quarters. The position peaked at $62K in Q4 2021. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • Ancora Advisors reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Ancora Advisors sold 2,098 TriSalus Life Sciences shares in Q4 2022, an estimated $21K.
  • Ancora Advisors first reported a position in TriSalus Life Sciences in Q3 2021 and held it in 5 quarters.
  • Ancora Advisors's TriSalus Life Sciences position peaked at $62K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Ancora Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.